Risk factors determine need for CTA for PE
Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.
Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.
CT angiograms were negative for pulmonary embolism (PE) in 90.2% of 2003 patients, according to researchers at the University of California, Irvine. Among the 197 patients positive for PE, 97.5% had one or more risk factors. The risk factors were age, gender, cancer, history of immbolization, excess estrogen rate, a history of venous thromboembolism, and disorders that cause blood to clot easily.
All risk factors except gender were considered statistically significant. Age of 65 years or older and immobilization were the most common risk factors in positive PE patients. Risk factor assessment had a sensitivity of 97.5% and a negative predictive value of 99% in all patients.
Of the patients negative for PE, 28.8% had no risk factors. Excluding age and gender brought that figure to 62%.
Results were published online June 15 (Epub ahead of print).
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
